Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-178-9 | CAS number: 16039-53-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 9.25 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 9.25 mg/m³
- Explanation for the modification of the dose descriptor starting point:
For a detailed explanation please refer to "additional information – workers".
- AF for dose response relationship:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for differences in duration of exposure:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for other interspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for intraspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for the quality of the whole database:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for remaining uncertainties:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 30.8 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 30.8 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For a detailed explanation please see box "additional information - workers".
- AF for dose response relationship:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for differences in duration of exposure:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for other interspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for intraspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for the quality of the whole database:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for remaining uncertainties:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Lactic acid is a ubiquitous and essential molecule of life; natural concentrations in vivo can and will vary widely. Lactate is non-toxic, any (local) effects are due to pH effects only; long-term DNELs are therefore considered not relevant. Therefore, the DNELs for zinc lactate were based solely on the toxicity of zinc.
The NOAEL of 50 mg Zn2+/day (0.83 mg/kg bw/day based on a woman’s body weight of 60 kg) derived from a 10-week oral study with human volunteers was used as a starting point for the risk characterisation for repeated dose toxicity (the value is taken as suggested in the submitted dossier for zinc chloride). The oral NOAEL for zinc lactate was calculated by scaling based on the molecular weight of the substance: 50 × 3.7 = 185 mg zinc lactate/day (3 mg/kg bw/day based on a woman’s body weight of 60 kg). As this NOAEL is based on human data, no additional assessment factors are required, i.e. to overall assessment factor is 1.
Oral
Oral DNELzinc lactate = 3 mg zinc lactate/kg bw/d
Table 1 : Assessment factors (AF) for zinc lactate
Uncertainties |
Assessment Factor |
Justification |
Interspecies |
1 |
No AF required; NOAEL derived from human experience through food supplementation |
Intraspecies -worker |
1 |
No AF required; NOAEL derived from human experience through food supplementation |
Intraspecies –general population |
1 |
No AF required; NOAEL derived from human experience through food supplementation |
Exposure duration |
1 |
No AF required; NOAEL derived from human experience through food supplementation |
Dose response and endpoint specific/severity issues |
1 |
No spefic AF required; NOAEL is considered to be reliable. |
Quality of database |
1 |
No specific AF required; limitations of all available studies have been identified and accounted for. |
This setting of the DNEL is fully in line with the approach from the EU Risk Assessment – part II Human Health (EU RAR 2004).
Derivation of the systemic exposure reflecting the oral NOAEL was done considering the bioavailability of soluble zinc compounds used in human volunteer studies: NOAELsyst = 50 mg Zn/d × 20 % = 10 mg Zn/d. This internal dose was used as a starting point in determining the dermal and inhalatory DNELs, by route-to-route extrapolation.
Dermal
The bioavailability of soluble zinc compounds following dermal exposure was considered to be 2 % (value as suggested in the submitted zinc chloride dossier).
dermal NOAELZn = 10 mg Zn/d/2 % = 500 mg Zn/d
dermal NOAELzinc lactate= (500 × 3.7)/60 = 30.8 mg zinc lactate/kg bw/d
No assessment factor is considered to be required as the original dose descriptor was derived from appropriate human volunteer studies.
Dermal DNELzinc lactate (worker, consumer) = 30.8 mg zinc lactate/kg bw/d
No further differentiation between worker and consumer DNELs is considered necessary.
Inhalatory
Derivation of the inhalatory DNEL is also based on the internal dose calculated based on the oral NOAEL. The bioavailability of soluble zinc compounds, including zinc lactate, following inhalatory exposure was considered to be 40 % (value as suggested in the submitted zinc chloride dossier).
NOAELZn = 10 mg Zn/d /40 % = 25 mg Zn/d
NOAELzinc lactate = 25 × 3.7 = 92.5 mg zinc lactate/d
Corrected dose descriptor for workers considering a breathing volume of 10m³ per 8 h shift:
Inhalatory NOAECzinc lactate = 92.5 mg/10 m³/d = 9.25 mg/m³
Corrected dose descriptor for consumers considering a breathing volume of 20 m³ per day inhalatory NOAEL = 92.5 mg/20 m³/d = 4.63 mg/m³
No assessment factor is considered to be required as the original dose descriptor was derived from appropriate human volunteer studies; hence the DNELs are as follows:
Inhalatory DNELzinc lactate worker = 9.25 mg/m³
Inhalatory DNELzinc lactate consumer = 4.63 mg/m³
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 4.63 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 4.63 mg/m³
- Explanation for the modification of the dose descriptor starting point:
For a detailed explanation please refer to "additional information - workers".
- AF for dose response relationship:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for differences in duration of exposure:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for other interspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for intraspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for the quality of the whole database:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for remaining uncertainties:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 30.8 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 30.8 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For a detailed explanation please refer to "additional information - workers".
- AF for dose response relationship:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for differences in duration of exposure:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for other interspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for intraspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for the quality of the whole database:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for remaining uncertainties:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 3 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 1
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 3 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
For detailed information please refer to "additional information - workers".
- AF for dose response relationship:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for differences in duration of exposure:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for interspecies differences (allometric scaling):
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for other interspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for intraspecies differences:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for the quality of the whole database:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
- AF for remaining uncertainties:
- 1
- Justification:
- No AF required; NOAEL has been derived from human experience through food supplementation
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- acute toxicity
- Route of original study:
- Oral
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
For detailed explanation please refer to "additional information - workers".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.